Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
DEKA Biosciences
Peking University First Hospital
Celldex Therapeutics
European Organisation for Research and Treatment of Cancer - EORTC